Uveitis   

Patient with a history of presumed benign ethnic neutropenia: PMN 1.5 prior to azathioprine and 1.2 after starting. The patient has an intolerance to ...

The patient has no extraocular features of a spondyloarthropathy and is on methotrexate. No active eye disease for past 1 year.

Patient with history of toxoplasma chorioretinitis, currently on oral and topical prednisone. 

Is the approach different from uveitis immunosuppression?

Are there specific features that suggest drug-induced uveitis versus de novo uveitis?

Are IL-17 or IL-23 inhibitors helpful?

Patient was previously well controlled on methotrexate, which was discontinued during cancer treatment.